Current studies have shown that C/EBPβ/AEP signaling is activated by gut dysbiosis in mouse models of AD, whereas C/EBPβ/AEP signaling and arachidonic acid–associated inflammatory enzymes are diminished in germ‐free mice. Here, CEBPB is linked to Alzheimer disease.